Prevention and management of hearing loss in patients receiving ototoxic medications

Following the efforts of patient advocates, the World Health Organization published updated guidelines for management of multidrug-resistant tuberculosis in 2018 that advised against the routine use of ototoxic second-line injectable drugs (amikacin, capreomycin and kanamycin). Although hearing loss...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindeborg, Michael M, Jung, David H, Chan, Dylan K, Mitnick, Carole D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Health Organization 2022
Materias:
Policy & Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706352/
https://www.ncbi.nlm.nih.gov/pubmed/36466201
http://dx.doi.org/10.2471/BLT.21.286823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706352/
https://www.ncbi.nlm.nih.gov/pubmed/36466201
http://dx.doi.org/10.2471/BLT.21.286823

Ejemplares similares